We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Legal & General Global Healthcare & Pharmaceutical Class C - Income (GBP)

Sell:80.53p Buy:80.53p Change: 0.15p (0.19%)
Prices as at 1 September 2026
Sell:80.53p
Buy:80.53p
Change: 0.15p (0.19%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 1 September 2026
Sell:80.53p
Buy:80.53p
Change: 0.15p (0.19%)
Prices as at 1 September 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 93.94%
UK Equities 5.61%
Cash and Equiv. 0.45%
Mutual Funds 0.00%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 11.41% USA Pharmaceuticals & Biotechnology
2 JOHNSON & JOHNSON 7.70% USA Pharmaceuticals & Biotechnology
3 ABBVIE 5.59% USA Pharmaceuticals & Biotechnology
4 UNITEDHEALTH GROUP INCORPORATED 4.77% USA Health Care Providers
5 MERCK & CO INC(NEW) 4.03% USA Pharmaceuticals & Biotechnology
6 ROCHE HOLDING AG 3.93% CHE Pharmaceuticals & Biotechnology
7 NOVARTIS AG 3.67% CHE Pharmaceuticals & Biotechnology
8 ASTRAZENECA 3.21% GBR Pharmaceuticals & Biotechnology
9 THERMO FISHER SCIENTIFIC 2.66% USA Medical Equipment & Services
10 AMGEN 2.60% USA Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account